Skip to main content

Table 5 Treatment groups by duration and agents

From: Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts

Treatment Groups n %
Treated < 1 month or never 54 28.9
Treatment ≥1 month 133 71.1
Treatment > 3 months 123 65.8
Off treatment ≥12 months 22 11.8
Prednisone 131 70.1
Methylprednisolone 13 7.0
Methotrexate 59 31.6
Azathioprine 9 4.8
Mycophenolic acid 13 7.0
Hydroxychloroquine 16 8.6
Infliximab 14 7.5